Anticancer Drugs Medicine Oncology Pharmacology Physiotherapy Tivozanib

Tivozanib (Mechanism of Action)

In this article we will discuss Tivozanib (Mechanism of Action)

In this article, we will discuss Tivozanib (Mechanism of Action). So, let’s get started.

Mechanism of Action

Tivozanib is a tyrosine kinase inhibitor. In vitro cellular kinase assays demonstrated that tivozanib inhibits phosphorylation of vascular endothelial growth factor receptor (VEGFR)-1, VEGFR-2 and VEGFR-3 and inhibits other kinases including c-kit and PDGFR β at clinically relevant concentrations. In tumor xenograft models in mice and rats, tivozanib inhibited angiogenesis, vascular permeability, and tumor growth of various tumor cell types including human renal cell carcinoma.


Exposure-Response Relationship
Tivozanib exposure-response relationships and the time course of pharmacodynamic response have not been fully characterized.
Cardiac Electrophysiology
At the recommended dose of Tivozanib, no large mean increases (i.e., 20 msec) in QTc interval were observed.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.